Tenaya Therapeutics Soars 10.41% on Analyst Price Cut

On June 9, 2025, Tenaya Therapeutics' stock surged by 10.41% in pre-market trading, marking a significant rise that has caught the attention of investors and analysts alike.

Canaccord Genuity Group recently adjusted their target price for Tenaya Therapeutics, lowering it from $18.00 to $6.00 while maintaining a "buy" rating. This move reflects the firm's updated outlook on the company's prospects, which could influence investor sentiment and future stock performance.

Technical analysis indicates that Tenaya Therapeutics' share price is currently at 0.63, with an 8-day exponential moving average of 0.52. This technical indicator suggests a buy signal, which may attract traders looking for short-term gains.

Investors are also speculating about potential catalysts that could drive further stock movement. The recent short squeeze run has sparked interest, but many are awaiting concrete results or news to sustain any gains. This anticipation could lead to increased volatility in the coming days.